BioNTech SE (BNTX) Gross Profit (2018 - 2025)
BioNTech SE (BNTX) posted Gross Profit of $668.3 million for Q4 2025, down 58.29% sequentially from $1.6 billion in Q3 2025, and down 99.98% YoY from $3526.1 billion in Q4 2024.
BioNTech SE (BNTX) Gross Profit (2018 - 2025) Analysis & Trends
BioNTech SE has reported Gross Profit for 8 years, with the latest figure at $668.3 million in Q4 2025.
- Quarterly Gross Profit fell 99.98% year-over-year to $668.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 billion (down 99.93% YoY) and the FY2025 annual result came in at $2.5 billion, up 6.6% from the prior year.
- Gross Profit declined to $668.3 million in Q4 2025 per BNTX's latest filing, from $1.6 billion in the prior quarter.
- Over five years, Gross Profit peaked at $3526.1 billion in Q4 2024 and troughed at $5.2 million in Q2 2023.
- A 5-year average of $178.5 billion and a median of $1.5 billion in 2023 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2021 and 2024: Gross Profit tumbled 100.0% in 2021, then surged 252014.16% in 2024.
- Over 5 years, Gross Profit stood at $5.7 billion in 2021, then decreased by 26.21% to $4.2 billion in 2022, then plunged by 66.52% to $1.4 billion in 2023, then soared by 252014.16% to $3526.1 billion in 2024, then plunged by 99.98% to $668.3 million in 2025.
- According to Business Quant data, Gross Profit over the past three periods registered $668.3 million, $1.6 billion, and $208.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|